Of 9 cases (25%) with intermediate grade dysplasia (IPMN, n = 5 and MCN, n = 4), three (30%) showed mutations in three additional genes (TP53, CDKN2A, APC). This evidence concerns the gene TP53 and pancreatic intraductal papillary-mucinous neoplasm.